Ausgabe 6/2015
Inhalt (10 Artikel)
Estimated human absorbed dose for 68Ga-ECC based on mice data: comparison with 67Ga-ECC
Saeed Shanehsazzadeh, Hassan Yousefnia, Amir Reza Jalilian, Samaneh Zolghadri, Afsaneh Lahooti
Role of 64CuCl2 PET/CT in staging of prostate cancer
Enza Capasso, Silvia Durzu, Sara Piras, Shahin Zandieh, Peter Knoll, Alexander Haug, Marcus Hacker, Carlo Meleddu, Siroos Mirzaei
Impact of residual 18F-fluoride in 18F-FDOPA for the diagnosis of neuroblastoma
Ya-Yao Huang, Kai-Yuan Tzen, Yen-Lin Liu, Ching-Hong Chiu, Chia-Ling Tsai, Hsiang-Ping Wen, Kuang-Hua Tang, Chien-Chu Liu, Chyng-Yann Shiue
Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands
Azusa Tokue, Tetsuya Higuchi, Yukiko Arisaka, Takahito Nakajima, Hiroyuki Tokue, Yoshito Tsushima
Optimized production and quality control of 68Ga-EDTMP for small clinical trials
Alireza Mirzaei, Amir R. Jalilian, Ali Badbarin, Mohammad Mazidi, Fatemeh Mirshojaei, Parham Geramifar, Davood Beiki
Additional information gained by positron emission tomography with 68Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors
Yuji Nakamoto, Kohei Sano, Takayoshi Ishimori, Masashi Ueda, Takashi Temma, Hideo Saji, Kaori Togashi
99mTc-3PRGD2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab
Qingjie Ma, Kaiyin Min, Ting Wang, Bin Chen, Qiang Wen, Fan Wang, Tiefeng Ji, Shi Gao
Ventilation/perfusion SPECT or SPECT/CT for lung function imaging in patients with pulmonary emphysema?
Vera Froeling, Uwe Heimann, Ralf-Harto Huebner, Thomas J. Kroencke, Martin H. Maurer, Felix Doellinger, Dominik Geisel, Bernd Hamm, Winfried Brenner, Nils F. Schreiter
[18F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study
Eliot T. McKinley, Jennifer M. Watchmaker, A. Bapsi Chakravarthy, Jeffrey A. Meyerhardt, Jeffrey A. Engelman, Ronald C. Walker, M. Kay Washington, Robert J. Coffey, H. Charles Manning
Draft guidelines regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors
Seigo Kinuya, Keiichiro Yoshinaga, Tetsuya Higuchi, Megumi Jinguji, Hiroaki Kurihara, Hiroshi Kawamoto